Quest Diagnostics Net Worth 2010-2025 | DGX

Interactive chart of historical net worth (market cap) for Quest Diagnostics (DGX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Quest Diagnostics net worth as of August 28, 2025 is $20.04B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.039B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) United States $12.434B 24.84
DaVita (DVA) United States $9.726B 13.91
Elanco Animal Health (ELAN) United States $9.166B 20.50
Chemed (CHE) United States $6.585B 22.06
RadNet (RDNT) United States $5.522B 199.42
Option Care Health (OPCH) United States $4.666B 19.97
LifeStance Health (LFST) United States $2.131B 0.00
Addus HomeCare (ADUS) United States $2.126B 22.88
Astrana Health (ASTH) United States $1.756B 61.43
Aveanna Healthcare Holdings (AVAH) United States $1.638B 30.15
U.S Physical Therapy (USPH) United States $1.258B 31.47
Atai Life Sciences (ATAI) Germany $0.997B 0.00
Pennant (PNTG) United States $0.840B 29.62
Daxor (DXR) United States $0.055B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.054B 0.00
Psychemedics (PMD) United States $0.000B 0.00